Compare Novartis with WYETH LTD - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs WYETH LTD - Comparison Results

NOVARTIS     Change

Novartis is a 76% subsidiary of Novartis AG - Switzerland and has a countrywide presence in the healthcare business. While pharmaceuticals contributes 70% to total revenues (FY10), generics (6%), consumer healthcare i.e. OTC (14%) and animal health (... More

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS WYETH LTD NOVARTIS/
WYETH LTD
 
P/E (TTM) x 1,877.0 27.7 6,770.8% View Chart
P/BV x 24.9 5.3 465.8% View Chart
Dividend Yield % 1.8 1.3 139.2%  

Financials

 NOVARTIS   WYETH LTD
EQUITY SHARE DATA
    NOVARTIS
Mar-19
WYETH LTD
Mar-13
NOVARTIS/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs9801,044 93.8%   
Low Rs600818 73.4%   
Sales per share (Unadj.) Rs198.7298.6 66.6%  
Earnings per share (Unadj.) Rs21.057.2 36.6%  
Cash flow per share (Unadj.) Rs22.358.4 38.1%  
Dividends per share (Unadj.) Rs10.0017.00 58.8%  
Dividend yield (eoy) %1.31.8 69.3%  
Book value per share (Unadj.) Rs307.5249.5 123.3%  
Shares outstanding (eoy) m24.6922.72 108.7%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.03.1 127.5%   
Avg P/E ratio x37.716.3 231.6%  
P/CF ratio (eoy) x35.515.9 222.7%  
Price / Book Value ratio x2.63.7 68.8%  
Dividend payout %47.729.7 160.6%   
Avg Mkt Cap Rs m19,50821,157 92.2%   
No. of employees `0000.60.5 118.1%   
Total wages/salary Rs m1,171400 292.8%   
Avg. sales/employee Rs Th8,445.413,787.4 61.3%   
Avg. wages/employee Rs Th2,015.7813.0 247.9%   
Avg. net profit/employee Rs Th891.02,643.3 33.7%   
INCOME DATA
Net Sales Rs m4,9076,783 72.3%  
Other income Rs m783353 222.0%   
Total revenues Rs m5,6897,136 79.7%   
Gross profit Rs m1231,617 7.6%  
Depreciation Rs m3227 119.5%   
Interest Rs m166 289.1%   
Profit before tax Rs m8581,938 44.3%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m340632 53.8%   
Profit after tax Rs m5181,301 39.8%  
Gross profit margin %2.523.8 10.5%  
Effective tax rate %39.632.6 121.5%   
Net profit margin %10.619.2 55.0%  
BALANCE SHEET DATA
Current assets Rs m8,0556,984 115.3%   
Current liabilities Rs m1,8502,056 90.0%   
Net working cap to sales %126.472.6 174.1%  
Current ratio x4.43.4 128.2%  
Inventory Days Days4599 45.3%  
Debtors Days Days3424 141.7%  
Net fixed assets Rs m150244 61.3%   
Share capital Rs m123227 54.3%   
"Free" reserves Rs m7,4695,441 137.3%   
Net worth Rs m7,5925,668 133.9%   
Long term debt Rs m025 0.0%   
Total assets Rs m9,8247,901 124.3%  
Interest coverage x54.9353.3 15.6%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.50.9 58.2%   
Return on assets %5.416.5 32.9%  
Return on equity %6.822.9 29.7%  
Return on capital %11.534.0 33.8%  
Exports to sales %00.2 0.0%   
Imports to sales %036.3 0.0%   
Exports (fob) Rs mNA15 0.0%   
Imports (cif) Rs mNA2,465 0.0%   
Fx inflow Rs m5815 378.9%   
Fx outflow Rs m1,3262,677 49.5%   
Net fx Rs m-1,269-2,662 47.7%   
CASH FLOW
From Operations Rs m-1,943923 -210.4%  
From Investments Rs m2,742317 865.4%  
From Financial Activity Rs m-298-481 62.0%  
Net Cashflow Rs m501759 66.0%  

Share Holding

Indian Promoters % 0.0 0.0 -  
Foreign collaborators % 75.0 51.1 146.8%  
Indian inst/Mut Fund % 2.0 11.3 17.7%  
FIIs % 1.6 7.2 22.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.5 30.4 70.7%  
Shareholders   41,647 21,978 189.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   DISHMAN PHARMA  ELDER PHARMA  ALEMBIC LTD  DR. DATSONS LABS  WOCKHARDT  

Compare NOVARTIS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Surges 450 Points; HDFC Bank & IndusInd Bank Top Gainers(12:30 pm)

Share markets in India are trading on a positive note. Benchmark indices rallied over 1% today tracking massive buying momentum in Asian peers and foreign fund inflows.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (1QFY20); Net Profit Down 92.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NOVARTIS has posted a net profit of Rs 8 m (down 92.1% YoY). Sales on the other hand came in at Rs 1 bn (down 20.8% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (4QFY19); Net Profit Down 26.2% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, NOVARTIS has posted a net profit of Rs 195 m (down 26.2% YoY). Sales on the other hand came in at Rs 1 bn (down 11.9% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY19); Net Profit Down 31.3% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, NOVARTIS has posted a net profit of Rs 129 m (down 31.3% YoY). Sales on the other hand came in at Rs 1 bn (down 13.1% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (2QFY19); Net Profit Down 64.1% (Quarterly Result Update)

Nov 21, 2018 | Updated on Nov 21, 2018

For the quarter ended September 2018, NOVARTIS has posted a net profit of Rs 94 m (down 64.1% YoY). Sales on the other hand came in at Rs 1 bn (down 36.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Be Prepared to Profit from the Coming Crash in Oil Prices(Fast Profits Daily)

Jun 25, 2020

The stability in crude oil prices will not last much longer. Be ready to make fast profits when the time comes to short crude.

Tata Motors Tripled in 18 Months but You Can Do Even Better. Here's How...(Profit Hunter)

Jun 24, 2020

Rahul is ready for a repeat of his famous 2008 Tata Motors call.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Jul 6, 2020 02:53 PM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS - WOCKHARDT COMPARISON

COMPARE NOVARTIS WITH

MARKET STATS